Switch to हिंदी

Health, Fitness, Beauty & Diet | Pregnancy & Parenting | Diseases & Home Remedies | TheHealthSite.com

Health, Fitness, Beauty & Diet | Pregnancy & Parenting | Diseases & Home Remedies | TheHealthSite.com

हिंदी
  • Health A-Z
  • Diabetes
  • Diseases
    • Type 1 Diabetes
    • Type 2 Diabetes
    • Cancer
    • Heart Attack
    • Pneumonia
    • Diseases A-Z
  • Diet & Fitness
    • Weight Management
    • Exercise & Body Building
    • Diet & Recipes
    • Yoga
  • Coronavirus
  • News
  • Pregnancy
    • Conceiving
    • Infertility
    • Labour & Delivery
    • Pregnancy week-by-week
    • Breastfeeding
    • Baby Names
  • Beauty
    • Skin
    • Hair
    • Grooming
  • Photos
  • Videos
Home / Health News / Ranbaxy launches drug to treat uncomplicated malaria

Ranbaxy launches drug to treat uncomplicated malaria

Ranbaxy laboratories today launched a new antimalarial drug, Synriam to treat malaria caused by plasmodium falciparum parasite. The drug will treat uncomplicated malaria. The research, which took plac

By: Admin   | | Updated: April 26, 2012 8:03 am
Tags: Plasmodium falciparum  Ranbaxy  Synriam  WHO  World Malaria Day 2012  
healthy grocery shopping

Ranbaxy laboratories today launched a new antimalarial drug, Synriam to treat malaria caused by plasmodium falciparum parasite. The drug will treat uncomplicated malaria. The research, which took place for nine years, was partly supported by the Indian government. Also Read - “Vaccines do not equal zero Covid": WHO calls for sustained efforts to control virus transmission

Also Read - WHO chief self quarantines after coming in contact with COVID-19 infected person



Clinical trials in India, Tanzania, and Thailand have suggested that the drug has an amazing 95% cure rate and could serve as alternative to existing anti-malarial therapy. Senior Ranbaxy officials announced today that the drug would be made available in India at Rs 130 for three tablets, and treatment would involve taking a single tablet for three days. Also Read - Coronavirus update: Cases surge in South Korea, WHO fears spread to African countries

“Almost 77 percent of the 2.5 million malaria patients in South East Asia are in India. Synriam will certainly become the preferred option in the hands of doctors to fight malaria, which annually claims half a million lives globally,” Sawhney said.

The drug is a combination of two molecules arterolane, discovered and patented several years ago by Professor Jonathan Vennestrom, a medicinal chemistry expert at the University of Nebraska Medical Centre in the US and piperaquine, an anti-malarial known since the 1960s. Arterolane is a short-acting anti-malarial molecule and piperaquine is a long-acting molecule. We ve combined the two to create a new combination therapy exactly on lines recommended by the World Health Organisation,” said Sudershan Arora, head of research at Ranbaxy.

India s department of science and technology (DST) contributed about Rs 5 crore to the research. One of the basic objectives of the research was to make the salt structure of arterolane to increase its availability in the body. Public health specialists estimate that about half of India s estimated 1.5 million cases of malaria each year are caused by the plasmodium falciparum parasite, the others are caused by Plasmodium vivax .

This new drug is intended for the treatment of uncomplicated falciparum malaria not for severe malaria (also known as malignant malaria) which requires different treatment strategies, said Neena Valecha, a senior scientist at the National Institute of Malaria Research, New Delhi, who was involved in assessing the clinical trials of the drug in India. In 2010, malaria caused an estimated 655,000 deaths worldwide. About 560,000 of the victims were children under five years of age, which means malaria killed one child every minute.

Malaria: All you need to know

WHO s strategy to fight Malaria: Test, Treat, Track

Published : April 26, 2012 7:59 am | Updated:April 26, 2012 8:03 am
Read Disclaimer

Low-dose aspirin taken daily cuts cancer risk - Study

Low-dose aspirin taken daily cuts cancer risk - Study

Research: Eating disorders linked to traumatic experiences

Research: Eating disorders linked to traumatic experiences

Please Wait. Article Loading ....

Coronavirus Updates

Coronavirus Updates

Stay Informed, Be Safe

  • Obesity, alcohol consumption can lower effectiveness of Covid-19 vaccines
  • ‘Don’t take Covid-19 vaccine shot if...': Covaxin company warns people amid concerns
  • Covid-19 vaccine alert: Covishield not advised to those allergic to any of its ingredients
  • Almost 30% of recovered COVID-19 patients develop complications within 5 months, over 12% die
  • COVID-19 vaccine side effects: Loss of sensation in arms and more reported by Pune health workers

Health Calculators

BMI Calculator
bmi Calculator
Ideal Body Weight
ideal body weight
Daily Calorie Intake
Daily calorie intake
Calories Burned
calories burned

Related Stories

Catastrophic moral failure: WHO warns against unequal COVID-19 vaccine distribution

Catastrophic moral failure: WHO warns against unequal COVID-19 vaccine distribution

Covid-19 may eventually resemble the common cold in future, scientists predict

Covid-19 may eventually resemble the common cold in future, scientists predict

Despite vaccines, Covid-19 herd immunity won't be achieved in 2021: WHO

Despite vaccines, Covid-19 herd immunity won't be achieved in 2021: WHO

“Vaccines do not equal zero Covid

“Vaccines do not equal zero Covid": WHO calls for sustained efforts to control virus transmission

WHO chief self quarantines after coming in contact with COVID-19 infected person

WHO chief self quarantines after coming in contact with COVID-19 infected person

Health News in Hindi

स्वास्थ्य मंत्रालय ने कहा, कोरोनावायरस का टीका लेने से नहीं हुई है कर्नाटक, उप्र में मौतें, डेथ की वजह है ये गंभीर बीमारी

Karishma Kapoor Beauty Secrets: करिश्मा कपूर की ग्लोइंग स्किन का सीक्रेट है माचा टी पाउडर, इस खास हर्बल चाय से बना फेस पैक लगाती हैं करिश्मा

Unhealthy Ways of Weight Loss: ये हैं वेट लॉस के ग़लत तरीके, जो सेहत पर पड़ सकते हैं भारी, कहीं आप तो नहीं आज़माते इन्हें ?

Coronavirus Vaccine Effectiveness: मोटापा कर सकता है कोविड-19 वैक्सीन को बेअसर, एक्सपर्ट्स ने किया दावा

कोरोना वायरस ने आपके दिल को कर दिया है कमजोर बताते हैं ये 4 संकेत, जानें कहीं आपका दिल तो नहीं हुआ कमजोर

Read All

Recent Posts

  • Obesity, alcohol consumption can lower effectiveness of Covid-19 vaccines
  • Green Mediterranean diet could benefit people with non-alcoholic fatty liver disease
  • Eluru-like mysterious illness emerges in Andhra Pradesh’s Pulla village
  • ‘Don’t take Covid-19 vaccine shot if…’: Covaxin company warns people amid concerns
  • Androgen therapy proposed as alternative treatment for breast cancer: How it is different from endocrine therapy?

About The health Site

TheHealthSite.com is India's largest health site with more than 40 lakh unique visitors per month. We focus on fitness, beauty, health, pregnancy and more.

Most popular health and wellness website in India in 2012 at the Website of the year awards.

health@corp.india.com
+91 – 22 – 6697 1234
Landline Phone number 91 – 22 – 2490 0302.

ZEE ENTERTAINMENT ENTERPRISES LTD, 18th floor, A-Wing, Marathon Futurex, N. M. Joshi Marg, Lower Parel, Mumbai, Maharashtra 400013.

Useful Links

  • Weight Loss
  • Keto Diet Tips
  • Skin Care Tips
  • Intermittent Fasting
  • Apple Cider Vinegar
  • Ashwagandha
  • Cancer
  • Pneumonia
  • Diarrhoea
  • Dengue
  • Typhoid
  • Tuberculosis
  • Chickenpox
  • Chikungunya
  • Depression
  • Hepatitis
  • Diabetes
  • Type 2 diabetes
  • Arthritis
  • Swine Flu
  • Baby Names
  • Cough and cold
  • Heart Attack
  • Breast Cancer
  • Ebola Virus
  • Dengue
  • Malaria
  • International Yoga Day
  • Hypotension
  • Heart Failure
  • Asthma
  • Brain Tumour
  • Celebrity Fitness
  • Goitre
  • HIV/AIDS

We respect your privacy

  • Disclaimer
  • Privacy Policy
  • Contact Us
  • Author Profiles

Copyright © 2021 Zee Entertainment Enterprises Limited. All rights reserved.